Critical Care
AHA/ASA Guideline for the management of patients with aneurysmal subarachnoid hemorrhage
29 May, 2023 | 11:16h | UTCTop Things to Know: 2023 Aneurysmal Subarachnoid Hemorrhage Guideline – American Heart Association
Commentary on Twitter
2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association https://t.co/IHZRkTR25t@American_Heart @American_Stroke @AHAScience @BrianHoh1 @drdangayach @CPDerdeyn pic.twitter.com/I2JdXnHuXp
— Stroke AHA/ASA (@StrokeAHA_ASA) May 23, 2023
RCT | Communication-priming intervention boosts goals-of-care discussions for seriously ill patients
29 May, 2023 | 11:12h | UTCIntervention to Promote Communication About Goals of Care for Hospitalized Patients With Serious Illness: A Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Conversations on Goals of Care With Hospitalized, Seriously Ill Patients – JAMA (free for a limited period)
See also: Visual Abstract
Commentary: Some Surrogate Endpoints Are Fine – By Dr John Mandrola
M-A | Hydrocortisone shows no significant impact on 90-day mortality in septic shock patients
29 May, 2023 | 11:06h | UTCPatient-Level Meta-Analysis of Low-Dose Hydrocortisone in Adults with Septic Shock – NEJM Evidence
Consensus Paper | Cardiac arrest in the perioperative period
29 May, 2023 | 11:04h | UTC
Guideline | Investigation and management of acute transfusion reactions
29 May, 2023 | 11:02h | UTC
ISPD Catheter-related infection recommendations
29 May, 2023 | 11:00h | UTCISPD Catheter-related Infection Recommendations: 2023 Update – Peritoneal Dialysis International
Guideline | Targeted temperature management in intracerebral, subarachnoid hemorrhage and acute ischemic stroke
29 May, 2023 | 10:48h | UTC
Consensus Statement | Rationale and clinical application of antimicrobial stewardship principles in the intensive care unit
24 May, 2023 | 13:15h | UTC
M-A | Optimizing enteral nutrition delivery by implementing volume-based feeding protocol for critically ill patients
24 May, 2023 | 13:13h | UTC
Guideline | Assessment and early management of head injury
23 May, 2023 | 13:11h | UTCHead injury: assessment and early management – NICE
Commentary: NICE head injury guidelines 2023: Now who do we scan? – St Emilyn’s
Review | Microcirculatory dysfunction in cardiogenic shock
23 May, 2023 | 12:50h | UTCMicrocirculatory dysfunction in cardiogenic shock – Annals of Intensive Care
Ventilator associated tracheobronchitis and pneumonia: one infection with two faces
23 May, 2023 | 12:49h | UTC
Review | The esophageal balloon for respiratory monitoring in ventilated patients
23 May, 2023 | 12:40h | UTC
Editorial | Selective digestive decontamination – Pro
22 May, 2023 | 13:34h | UTCSelective digestive decontamination – Pro – Intensive Care Medicine (free for a limited period)
Commentary on Twitter
#SDD? One of few areas in critical care where large RCTs/SRs demonstrate consistent advantage, without evident side effects. Pivotal
📃 standardized formulation/protocols
📚 education
🧫 ABT stewardship + rigorous IPC strategies, monitoring ABTs use/AMR
🖇️ https://t.co/VOqudX6E6k pic.twitter.com/YN5DuXknDL— Intensive Care Medicine (@yourICM) May 21, 2023
Practice Guidance | Differential diagnosis of suspected COPD exacerbations in the acute care setting
15 May, 2023 | 13:26h | UTC
Commentary on Twitter
Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice
🔓 Open Access
🔗 https://t.co/aPiT06E2g4 pic.twitter.com/kF40aSS7Oo— ATS Blue Journal (@ATSBlueEditor) May 12, 2023
RCT | Prophylactic antibiotics show no statistically significant survival improvement in severe alcohol-related hepatitis
15 May, 2023 | 13:21h | UTCSummary: This multicenter, randomized, double-blind clinical trial aimed to determine the efficacy of amoxicillin-clavulanate combined with prednisolone compared to placebo combined with prednisolone on mortality in patients hospitalized with severe alcohol-related hepatitis. The study involved 284 patients from 25 centers in France and Belgium with biopsy-proven severe alcohol-related hepatitis, who were followed up for 180 days.
The primary outcome was all-cause mortality at 60 days, while secondary outcomes included mortality at 90 and 180 days, infection rates, hepatorenal syndrome, and changes in Model for End-stage Liver Disease (MELD) and Lille scores. The results showed no statistically significant difference in 60-day mortality between the two groups, with 17.3% in the amoxicillin-clavulanate group and 21.3% in the placebo group. However, infection rates at 60 days were significantly lower in the amoxicillin-clavulanate group compared to the placebo group.
It is worth noting that the study may have been underpowered, as the absolute risk difference of 4% did not achieve statistical significance. In conclusion, the combination of amoxicillin-clavulanate and prednisolone did not show a statistically significant improvement in 2-month survival in patients hospitalized with severe alcohol-related hepatitis compared to prednisolone alone. These findings do not support the use of prophylactic antibiotics to improve survival in this patient population, but the potential underpowered nature of the study should be considered.
Article: Effect of Prophylactic Antibiotics on Mortality in Severe Alcohol-Related Hepatitis: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)
Commentary on Twitter
Among patients with severe alcohol-related #hepatitis receiving prednisolone, amoxicillin-clavulanate did not improve survival at 60-day follow-up compared with placebo. https://t.co/4XkVL2CTsP #DDW pic.twitter.com/9sh5vennkK
— JAMA (@JAMA_current) May 9, 2023
Therapeutic plasma exchange: Core curriculum 2023
15 May, 2023 | 13:14h | UTCTherapeutic Plasma Exchange: Core Curriculum 2023 – American Journal of Kidney Diseases
Commentary on Twitter
Therapeutic Plasma Exchange: Core Curriculum 2023 https://t.co/6IoHXeAzyO (FREE)@Elena_Cervants @JohnSperati pic.twitter.com/3OVgAhXjCv
— AJKD (@AJKDonline) May 7, 2023
Review | Intensive care unit–acquired weakness in patients with acute kidney injury
15 May, 2023 | 13:12h | UTC
Commentary on Twitter
Intensive Care Unit–Acquired Weakness in Patients With Acute Kidney Injury: A Contemporary Review https://t.co/I7JXcb11VY (FREE) @NephCrit_NM @KirbyMayerDPT @Ben_Griffin_MD @NRG3000 @njenkinsphd @FGonzalezSeguel @javo_neyra #AKI pic.twitter.com/8nDSSQFMwa
— AJKD (@AJKDonline) May 13, 2023
Brief Review | Coagulation support during perioperative bleeding management
15 May, 2023 | 13:01h | UTCCoagulation support during perioperative bleeding management – Intensive Care Medicine
Commentary on Twitter
Coagulation & perioperative bleeding
🩸fibrinogen source/dose/time
🩸Ca++: just vs citrated blood products?
🩸PCCs/factor concentrates
🩸TXA
🩸plasma: volume or coagulation?
🩸PLTs as primary components
🩸RBCs not just DO2
🩸targeted coagulation support
🖇️ https://t.co/lv1i5GoHBg pic.twitter.com/8BtuAE6gt8— Intensive Care Medicine (@yourICM) May 13, 2023
Review | Awake prone positioning in acute hypoxemic respiratory failure
15 May, 2023 | 12:56h | UTCAwake prone positioning in acute hypoxaemic respiratory failure – European Respiratory Review
M-A | Effectiveness of diaphragmatic ultrasound as a predictor of successful weaning from mechanical ventilation
15 May, 2023 | 12:46h | UTC
M-A | Endovascular therapy for stroke presenting beyond 24 hours
12 May, 2023 | 13:44h | UTC
Commentary on Twitter
Endovascular therapy for stroke presenting at >24 hours was associated with favorable clinical, safety, and procedural outcomes in this meta-analysis of 569 patients. https://t.co/DjoDDcr1mf
— JAMA Network Open (@JAMANetworkOpen) May 4, 2023
Review | Progress in the treatment of acute pulmonary embolism and chronic thrombo-embolic pulmonary hypertension/disease
12 May, 2023 | 13:24h | UTCSee all articles in the series here
Review | Takotsubo syndrome: more frequent in women, more dangerous in men
12 May, 2023 | 13:21h | UTCSee all articles in the series here
A review of bicarbonate use in common clinical scenarios
11 May, 2023 | 12:17h | UTCA Review of Bicarbonate Use in Common Clinical Scenarios – The Journal of Emergency Medicine